Abstract
Chromodomain helicase DNA binding domain (CHD) proteins, including CHD7 and CHD8, remodel chromatin to enable transcriptional programs. Both proteins are important for proper neural development as heterozygous mutations in Chd7 and Chd8 are causative for CHARGE syndrome and correlated with autism spectrum disorders, respectively. Their roles in mature neurons are poorly understood despite influencing the expression of genes required for cell adhesion, neurotransmission, and synaptic plasticity. The Drosophila homolog of CHD7 and CHD8, Kismet (Kis), promotes neurotransmission, endocytosis, and larval locomotion. Endocytosis is essential in neurons for replenishing synaptic vesicles, maintaining protein localization, and preserving the size and composition of the presynaptic membrane. Several forms of endocytosis have been identified including clathrin-mediated endocytosis, which is coupled with neural activity and is the most prevalent form of synaptic endocytosis, and activity-dependent bulk endocytosis, which occurs during periods of intense stimulation. Kis modulates the expression of gene products involved in endocytosis including promoting shaggy/GSK3β expression while restricting PI3K92E. kis mutants electrophysiologically phenocopy a liquid facets mutant in response to paradigms that induce clathrin-mediated endocytosis and activity-dependent bulk endocytosis. Further, kis mutants do not show further reductions in endocytosis when activity-dependent bulk endocytosis or clathrin-mediated endocytosis are pharmacologically inhibited. We find that Kis is important in postsynaptic muscle for proper endocytosis but the ATPase domain of Kis is dispensable for endocytosis. Collectively, our data indicate that Kis promotes both clathrin-mediated endocytosis and activity-dependent bulk endocytosis possibly by promoting transcription of several endocytic genes and maintaining the size of the synaptic vesicle pool.
Introduction
Neural communication relies on the coordinated release of neurotransmitter, which diffuses across the synaptic cleft and binds to postsynaptic receptors [1, 2]. Synaptic proteins facilitate processes required for proper neurotransmission and synaptic plasticity by inducing cellular changes in response to an action potential [3]. The mobilization and trafficking of synaptic vesicles constitute the presynaptic response to action potential-induced Ca2+ influx [4]. Thus, Ca2+-dependent release of neurotransmitter-containing vesicles, and the proteins that comprise vesicle release machinery and postsynaptic receptors, are important for mediating neural communication. Presynaptic neurons maintain distinct pools of neurotransmitter-filled vesicles that can be quickly mobilized upon stimulation. The localization of vesicles into these pools influences their temporal availability for release [5, 6]. Vesicles in the readily releasable pool are docked at presynaptic release sites and are the first to be released upon stimulation [7]. The reserve pool, however, may be more distal to sites of release and is mobilized upon high frequency stimulation to replenish the readily releasable pool [8, 9]. Both the readily releasable and reserve pools are replenished by recycling vesicles through endocytosis [10] and disruptions in these endocytic pathways compromise neurotransmitter release.
Endocytosis is a process that involves the internalization and scission of the plasma membrane and functions to recycle membrane-associated proteins and phospholipids. Several mechanisms of endocytosis have been characterized including clathrin-mediated endocytosis (CME), activity-dependent bulk endocytosis (ADBE), kiss-and-run, fast compensatory endocytosis, and ultrafast endocytosis [11, 12]. CME involves the recruitment of clathrin scaffold proteins that surround vesicles upon endocytic uptake and is the primary mode of synaptic vesicle recycling during basal neurotransmission [12, 13]. Conversely, ADBE initially occurs independently of clathrin and is used during high frequency neuronal stimulation to replenish reserve pool vesicles [12, 14]. Both processes facilitate synaptic vesicle recycling and are important for overall neuronal function. Mutations in endocytic machinery-encoding genes are associated with neurodevelopmental disorders [15] and neurodegenerative diseases [16].
The expression of synaptic gene products, including those required for endocytosis, is dynamically regulated by chromatin states. Chromatin regulatory proteins establish and maintain the epigenome, which consists of the cellular chemical modifications of DNA and histones [17]. Epigenetic changes in gene expression are required for synaptic remodeling during learning [18] and occur in both neurodevelopmental disorders [19] and neurodegenerative diseases [20]. The ATP-dependent chromodomain helicase DNA-binding (CHD) family proteins regulate neurodevelopmental processes [21] but are also expressed in mature neurons [22]. Given the partial overlap of misregulated genes shared between autism spectrum disorder and Alzheimer’s disease [23], a better understanding of how chromatin remodeling influences synaptic processes during both neurodevelopment and neurodegeneration is warranted. The link between neurodevelopmental and neurodegenerative diseases and the molecular pathways underlying their shared pathology are becoming increasingly clear. For example, mutations in the catalytic γ-secretase subunit, presenilin, impair postsynaptic development [24] and are also linked to aberrant proteolytic processing in familial Alzheimer’s disease [25]. How dysfunctional CHD proteins specifically impact synaptic function throughout neurodevelopmental and neurodegenerative disease pathways, however, is still poorly characterized.
Kismet (Kis) is the Drosophila homolog of group III CHD proteins, including CHD7 and CHD8 [21, 26]. The full length Kis isoform possesses two chromodomains that bind methylated histone residues and an ATPase domain that catalyzes nucleosome remodeling [26, 27]. These nucleosome modifications may activate or repress transcription depending on the binding sites exposed [28]. At the Drosophila neuromuscular junction (NMJ), Kis restricts axonal branching and bouton formation [29] and promotes glutamate receptor localization [30] and synaptic vesicle endocytosis [31]. Here, we find that Kis regulates ADBE and CME at the Drosophila NMJ possibly by regulating the expression of endocytosis-related gene products and maintaining vesicle pool sizes. We also show that Kis is important in postsynaptic cells for presynaptic vesicle endocytosis and Kis’s modulation of endocytosis is independent of ATPase domain activity.
Materials and methods
Drosophila stocks and husbandry
Fly stocks were maintained at 25°C with a 12 h light:dark cycle and fed Jazz Mix food (Fisher Scientific AS153). Nutri-Fly Instant Food (Genesee Scientific 66–118) was used for experiments where flies were raised on food containing compounds. Male and female larvae and adults were used for all experiments except for sggEP1576. The sggEP1576 mutation is on the first chromosome necessitating the use of only females of this and the control genotypes. Most fly stocks were obtained from the Bloomington Drosophila stock center including w1118 (RRID:BDSC_3605), dap160EP2543 (RRID:BDSC_3605), kisk13416 (RRID:BDSC_10442), lqfKG03016 (RRID:BDSC_13766), sggEP1576 (RRID:BDSC_11008), Actin5c-Gal4 (RRID:BDSC_30558), elavC155-Gal4 (RRID:BDSC_458), elav-Gal4 (RRID:BDSC_8760), D42-Gal4 (RRID:BDSC_8816), 24B-Gal4 (RRID:BDSC_1767), and repo-Gal4 (RRID:BDSC_7415). kisLM27 and UAS-kis-L were gifts from Dan Marenda [32]. UAS-CHD7 and UAS-kisK2060R were generated for this work.
Generation and expression of UAS-CHD7 and UAS-kisK2060R
Human CHD7 (NM_017780) was used to determine the Drosophila optimized CHD7 cDNA sequence. The kis-L (NM_001258889) cDNA sequence was used for kisK2060R but was modified by substituting CGA (encoding R) for AAA (encoding K) at codon 2059. cDNAs were synthesized by Thermo Fisher and included a NotI restriction site on the 5’ end and a XbaI site on the 3’ end. A Drosophila optimized V5 cDNA sequence (GGT AAG CCC ATC CCG AAC CCC CTG CTG GGT TTG GAC TCC ACT) was included upstream of the stop codon and XbaI restriction site. cDNAs were inserted into pUAST using the NotI and XbaI restriction sites and insertion was confirmed by DNA sequencing. Both constructs were injected into w1118 embryos using standard germline transformation methods (BestGene, Inc., Chino Hills, CA).
Reverse transcription PCR and qPCR
Central nervous systems (CNSs) were dissected from male and female third instar larvae in Roger’s Ringer solution (135 mM NaCl, 5 mM KCl, 4 mM MgCl2*6H2O, 1.8 mM CaCl2*2H2O, 5 mM TES, 72 mM Sucrose, 2 mM glutamate, pH 7.15), placed in Invitrogen RNAlater Stabilization Solution (Fisher Scientific AM7020), and stored at -20°C. 30 CNSs or 8–12 larvae per genotype were used for each technical replicate. RNA was isolated using the Invitrogen Purelink RNA Mini Kit (Fisher Scientific 12-183-025). RNA concentrations were obtained using an Implen Nanophotometer N50. 100 ng of RNA was used for each reaction. Primers were designed using PerlPrimer (v. 1.1.21). qRT-PCR was performed using the iTaq Universal SYBR Green One Step Kit (Bio-Rad 1725151) and a CFX Connect Real-Time PCR Detection System (Bio-Rad). At least four biological replicates each including three technical replicates were used for data analysis. 2-ΔΔC(t) values [33] were calculated by first subtracting the C(t) value of the target transcript reaction from the C(t) value for GAPDH to obtain ΔC(t) for each transcript. Next, the difference between control and kis mutant ΔC(t)s was calculated to obtain the 2-ΔΔC(t). 2-ΔΔC(t) were calculated using RNA samples isolated the same day with RT-qPCR reactions executed simultaneously. Student’s t-tests were used to determine if there was a statistical difference between control and kis mutant ΔC(t)s.
Immunocytochemistry and FM labeling
Third instar larvae were fillet dissected in Roger’s Ringer solution (135 mM NaCl, 5 mM KCl, 4 mM MgCl2*6H2O, 1.8 mM CaCl2*2H2O, 5 mM TES, 72 mM Sucrose, 2 mM glutamate, pH 7.15) on Sylgard (World Precision Instruments)-coated 60 mm dishes. Larvae were fixed for 30 min with 4% paraformaldehyde (Fisher Scientific F79500) in 1 x phosphate buffered saline (PBS, Midwest Scientific QS1200). Fixed larvae were placed in 1.5 ml centrifuge tubes containing PTX (1 x PBS + 0.1% Triton X-100, Fisher Scientific AAA16046AP) and washed three times for 10 min in PTX. After two 30 min washes in PBTX (1 x PBS + 0.1% Triton X-100 + 1% Bovine Serum Albumin, Fisher Scientific BP1600-100), rabbit α-V5 (1:1000, Sigma AB3792, RRID: AB_91591) was diluted in PBTX and applied overnight at 4°C. After primary antibodies were removed, larvae were washed three times for 10 min and two times for 30 min in PBTX. α-rabbit FITC (Jackson ImmunoResearch; RRID: AB_2337972) was diluted 1:400 in PBTX and applied for 2 h at room temperature with Cy3 HRP (1:125, Jackson ImmunoResearch, RRID: AB_2338959) and DAPI (1:500, ThermoFisher D1306, RRID: AB_2629482).
Endocytosis was measured as described by Verstreken et al. [34]. Briefly, third instar larvae were fillet dissected in Ca2+-free HL-3 (100 mM NaCl, 5 mM KCl, 10 mM NaHCO3, 5 mM HEPES, 30 mM sucrose, 5 mM trehelose, 10 mM MgCl2, pH 7.2). After one wash with Ca2+-free HL-3 and cutting the motor neurons, 4 μM FM 1-43FX (Fisher Scientific F35355) in HL-3 containing 90 mM KCl and 1.0 mM CaCl2 was applied for one minute. For endocytosis inhibition experiments, larvae were exposed to DMSO, 100 μM BAPTA-AM for 10 min, 25 μM EGTA-AM for 10 min, 200 μM Chlorpromazine for 30 min, 100 μM Dynasore for 10 min, or 200 μM Roscovitine for 30 min prior to one min stimulation with 90 mM KCl. Concentrations and treatment times were determined using previously published protocols (see results). Next, larvae were washed five times over 5–10 min in Ca2+-free HL-3. Larvae were fixed in 3.7% paraformaldehyde (Fisher Scientific) in Ca2+-free HL-3 for 5 min and then placed in 1.5 ml centrifuge tubes. Larvae were washed with Ca2+-free HL-3 containing 2.5% goat serum several times and with Ca2+-free HL-3 10 times over 10–15 min. A647 HRP (1:125, Jackson ImmunoResearch) was applied for 30 min in Ca2+-free HL-3 containing 5% goat serum. Next, larvae were washed with Ca2+-free HL-3 10 times over 10–15 min and mounted on slides with Vectashield (Vector Laboratories H1000).
An Olympus FV1000 confocal microscope was used to acquire images of 6/7 NMJs within segments 3 or 4 and ventral nerve cords. The former were acquired using a 60x oil immersion objective while the latter were acquired using a 40x oil immersion objective. Genotypes were labeled using the same reagents for each experimental replicate. The mean of all control acquisition settings was used for each experimental animal and approximately equal numbers of controls and experimental animals were imaged each day. Image z-stacks were constructed using Fiji [35]. Measurement of FM 1-43FX signal intensities was accomplished by calculating the relative fluorescence intensity, which was the difference between the synaptic fluorescence and background fluorescence, from each max projected z-stack slice. The mean relative fluorescence value of all slices was used as the NMJ fluorescence intensity for each NMJ and this is represented as a point on bar graphs.
Electrophysiology
Third instar larvae were fillet dissected in ice cold HL-3 containing 0.25 mM Ca2+ and glued to Sylgard (World Precision Instruments)-coated round 18 mm coverslips. After the nervous system was removed, larvae were rinsed once with room temperature HL-3 containing 1.0 mM Ca2+, which was used for recordings. Muscle 6 of body wall segments 3 or 4 was used for two electrode voltage clamp recordings. Electrodes were filled with 3 M KCl and used for recordings provided they demonstrated resistances of 10–30 MΩ. Recordings were acquired in pClamp (Molecular Devices, v. 11.1) and obtained from muscles clamped at -60 mV using an Axoclamp 900A amplifier (Molecular Devices) with input resistances <5 MΩ. Segmental nerves were stimulated with suction electrodes filled with HL-3 containing 1.0 mM Ca2+. Suprathreshold stimuli were administered from a Grass S88 stimulator with a SIU5 isolation unit (Grass Technologies). High frequency stimulation included stimuli administered at 0.2 Hz for 50 s, 20 Hz for 60 s, and 0.2 Hz for 50 s. Low frequency stimulation included 5 Hz stimulation for five minutes. Stock concentrations of each compound were diluted to 100 μM BAPTA-AM, 25 μM EGTA-AM, and 100 μM Dynasore in HL-3 containing 1.0 mM Ca2+ the day of recording and kept on ice. Working concentrations were allowed to warm to room temperature immediately before use. Vesicle pool sizes were assessed by incubating dissected larvae at room temperature for 20 min in freshly prepared 2 μM Bafilomycin in HL-3 containing 1 mM Ca2+. Concentrations and treatment times for all compounds were determined using previously published protocols (see results). mEJCs were recorded for 3 min followed by stimulation of the segmental nerve at 3 Hz for 10 min or at 10 Hz for 5 min. Recordings were digitized with a Digidata 1443 digitizer (Molecular Devices).
Recordings from approximately the same number of controls and experimental animals were obtained each day. All experiments included at least three biological replicates with sample sizes of 9–11 larvae as indicated in figure legends. Data were analyzed in Clampfit (v 11.1, Molecular Devices) and GraphPad Prism (v. 9.3.0). When trains of stimulation were delivered, eEJC amplitudes were normalized to the first eEJC. Multiple unpaired t-tests were used to determine if eEJC amplitudes differed over time.
Behavior
Third instar larvae were obtained from vials with Jazz Mix food and briefly wiped with a damp paintbrush to remove any debris. Larvae were then transferred to a 1.6% agar plate and allowed to freely wander for one minute to acclimate to crawling surface. After the acclimation period, larvae were moved to the behavior arena (a backlit 1.6% agar slab with overhead camera mount) and video recorded for 30 seconds with a Cannon EOS M50 camera at 29.97 frames per second. Recording started after larvae engaged in forward-directed motion. 899 frames were analyzed in Fiji (NIH ImageJ) with the wrMTrck plugin by Jesper S. Pedersen [36] to obtain values for average distances travelled, average and maximum velocities, and body lengths per second. XY coordinates of larval crawling paths were extracted from wrMTrck and graphed in Excel (Microsoft) to generate representative path tracings.
Experimental design and statistical analyses
All experiments included at least two biological replicates with approximately equal numbers of controls and experimental animals. Data analyses were performed with GraphPad Prism (v. 9.3.0 and 10.0.0). When data sets included one control group, for example comparison of mutant genotypes to w1118 controls, means were compared using unpaired t-tests. When data sets included two control groups, a one-way ANOVA was used followed by Tukey’s post hoc tests. Bartlett’s Test for homogeneity of variance was used to assess the variances between data sets. For experiments that included more than one outcrossed Gal4 control groups, the control groups were compared to determine if they statistically differed. If the Gal4 control groups did not statistically differ, they were combined and treated as a single control group. Bar graphs in figures represent the means and show sample sizes as individual points. Sample sizes indicate individual larvae except for the RT-qPCR experiments where the points represent one technical replicate. Statistical significance is represented on bar graphs as follows: * = <0.05, ** = <0.01, *** = <0.001 with error bars representing standard error of the mean (SEM). S1 Table shows the statistically significant p-values corresponding to each figure.
Results
Kismet influences transcription of gene products encoding CME- and ADBE-associated proteins
Presynaptic endocytosis replenishes synaptic vesicles [37], influences protein localization, and preserves the size and composition of the presynaptic membrane [38, 39]. We previously showed that that Kis promotes endocytosis by regulating transcription of endocytic genes and synaptic Dynamin (Dyn) localization. Specifically, mutations in kis increased AP2α but decreased dap160 and endophilin B (endoB) transcripts [31]. Each of these gene products is required for CME. Dap160/Intersectin is a scaffolding protein that recruits the clathrin adapter AP2 to the membrane [40] while endophilins recruit the GTPase, Dyn [41], and help induce curvature of the plasma membrane [42]. In this study, we sought to better understand the role of Kis in the distinct regulation of CME, ADBE, or both using the Drosophila NMJ. The Drosophila NMJ provides a well-established system to model mammalian neurotransmission as these synapses share common structural features and mechanisms of neurotransmitter release, vesicle endocytosis, and postsynaptic signaling [43].
To further investigate Kis’ regulation of endocytosis, we extended our analysis to gene products involved in CME, ADBE, or both. We used two kis mutant alleles for our analysis including the hypomorphic allele, kisk13416, and kisLM27, a null allele [29]. Because the latter is embryonic lethal, we used animals heterozygous for kisk13416 and kisLM27 to examine endocytic transcript levels via RT-qPCR. Of the 10 transcripts examined, PI3K92E, which encodes a catalytic subunit of the phosphatidylinositol 3-kinase (PI3K) enzyme, was increased in kisLM27/kisk13416 but not kisk13416 mutants compared with controls. In contrast, shaggy (sgg), which encodes Glycogen Synthase Kinase 3 (GSK3) was decreased in both kis mutants relative to w1118 controls (Fig 1). PI3K indirectly inhibits GSK3 activity thereby activating ADBE [44]. These data, taken together with our previous observations [31], suggest that Kis may regulate the expression of several CME and ADBE transcripts.
Kismet promotes CME and ADBE
To determine whether Kis is functionally involved in CME and ADBE, we assessed endocytosis via electrophysiology and uptake of the lipophilic dye FM 1-43FX. We first used a 20 Hz high frequency stimulation (HFS) protocol in 1.0 mM Ca2+ for one minute to promote ADBE [45, 46]. This was followed by 0.2 Hz stimulation to assess recovery, which requires the readily releasable pool of vesicles to be replenished by mobilization of the reserve pool [47]. We also assessed endocytosis in liquid facets (lqf) mutants because of its roles in CME and ADBE. Lqf, which is the Drosophila homolog of Epsin 1 [48], remodels the membrane and recycles synaptic vesicles during CME [37] and is dephosphorylated along with several other proteins to trigger ADBE [49]. Both kis and lqf mutants showed decreased evoked endplate junctional current (eEJC) amplitudes during HFS compared to controls (Fig 2A and 2B). Recovery from HFS was impaired in kis mutants from 40–50 seconds after HFS and at 40 seconds after HFS in lqf mutants (100–110 seconds in Fig 2A). These data indicate that kis and lqf mutants show impaired ADBE and recycling of vesicles after HFS.
Next, we used a low frequency stimulation (LFS) protocol consisting of five minutes of 5 Hz stimulation in 1.0 mM Ca2+ to promote CME [50] in kis and lqf mutants. eEJC amplitudes in controls were approximately 80% of the initial stimulus amplitudes 10–50 seconds after the onset of stimulation. Amplitudes continued to decline until they were approximately 67% of the initial stimulus at the end of stimulation. Although lqfk03016 mutant eEJC amplitudes were reduced to approximately 76% of the initial stimulus at the beginning and 57% at the end of stimulation, there was only a significant reduction in eEJC amplitudes at 170 seconds after onset of stimulation (Fig 3A and 3B). kisLM27/kisk13416 mutants exhibited a similar reduction as lqfk03016 mutants in initial eEJC amplitudes, which were approximately 72% of the first stimulus. There was a significant reduction in eEJC amplitudes in kis mutants at several time points from 160–260 seconds after the onset of stimulation when eEJC amplitudes were approximately 60–62% of the initial stimulus (Fig 3A and 3B). Reduced eEJC amplitudes in kis mutants when CME was induced suggests that Kis promotes CME.
If Kis regulates CME or ADBE, we would expect to observe no change in eEJC amplitudes during stimulation when CME or ADBE is inhibited. We used several putative inhibitors to target CME or ADBE in kis and lqf mutants. CME and ADBE require presynaptic increases in Ca2+ [51, 52]. Therefore, we used the Ca2+ chelators BAPTA, to inhibit both CME and ADBE, and EGTA, to inhibit ADBE [53]. CME is triggered by local increases in active zone Ca2+ initiated by the action potential [54] while ADBE is triggered when Ca2+ diffuses away from the active zone to the periactive zone [55]. BAPTA and EGTA are Ca2+ chelators that inhibit increases in Ca2+ at the periactive zone. Only BAPTA, however, inhibits the increases in Ca2+ at the active zone [56] because it has a faster on binding rate [57]. We also used Dynasore, an inhibitor of Dyn GTPase activity [58], to block CME. Dynasore does not affect Dyn’s affinity for GTP or its capacity to assemble on membranes [59]. After a 10 minute incubation, 100 μM Dynasore inhibited CME induced by LFS (S1 Fig) but did not affect ADBE (S2 Fig) in w1118 controls. The most pronounced effect on CME (S1 Fig) was observed from 160–250 sec. During this time, control eEJCs were 75.6–77.7% of the first response. In contrast, Dynasore treatment produced eEJCs that were 57.8–64.1% of the first response. Neither 100 μM BAPTA-AM nor 25 μM EGTA-AM affected CME or ADBE (S1 and S2 Figs) in controls after a 10 minute incubation. Therefore, we used Dynasore to determine if Kis functionally influences CME. Both kis and lqf mutants exhibited reduced eEJC amplitudes during LFS similar to that of controls after a 10 minute incubation with 100 μM Dynasore (Fig 3C and 3D). The similar reduction in LFS-induced eEJCs when CME was inhibited with Dynasore suggests that Kis and Lqf contribute to CME.
We extended our analyses of CME and ADBE to include additional inhibitors and endocytic mutants as negative controls. In addition to the lqfKG03016 mutant, which exhibits alterations in both CME and ADBE [37, 60], we used dap160EP2543 and sggEP1576 mutants, which have impaired CME [40] and ADBE [44], respectively. Endocytosis was examined using the lipophilic dye, FM 1–43FX, to label newly endocytosed synaptic vesicles [34] after one min stimulation with 90 mM KCl in 1.0 mM Ca2+. Stimulation using high K+ induces both CME and ADBE [61]. This stimulation paradigm resulted in decreased endocytosis, as indicated by a significant reduction in FM 1-43FX internalization, in all four mutants (Fig 4B, left). Next, larvae were pretreated with either 100 μM BAPTA-AM, 25 μM EGTA-AM, or 200 μM Roscovitine before one min stimulation with 90 mM KCl in 1.0 mM Ca2+. Each compound pretreatment led to a reduction in endocytosis in w1118 controls (S3 Fig). Roscovitine inhibits cyclin-dependent kinase 5, which is required for ADBE [62], by competing with ATP for the kinase domain [63]. Mutations in either dap160 or kis did not affect endocytosis when NMJs were pretreated with BAPTA or EGTA (Fig 4A, middle panels). Similar as lqfKG0301 and sggEP1576 mutants, however, kisLM27/kisk13416 mutants exhibited reduced endocytosis after pretreatment with the ADBE inhibitor, Roscovitine (Fig 4B). Given that kis mutants did not exhibit a further reduction in endocytosis when ADBE was inhibited by BAPTA or EGTA, Kis likely functionally influences ADBE.
We used the same protocol to assess whether Kis also functionally contributes to CME. We again used 100 μM Dynasore to inhibit CME. We also employed Chlorpromazine, which inhibits assembly of clathrin coats [64] possibly by interfering with Dyn-lipid binding [65]. Pretreatment with each compound led to a reduction in endocytosis w1118 controls (S3 Fig). None of the mutants examined exhibited changes in endocytosis after pretreatment with 200 μM Chlorpromazine while only sggEP1576 mutants exhibited a further decrease in endocytosis after pretreatment with 100 μM Dynasore (Fig 5). These data, coupled with our electrophysiological analyses, suggest that Kis functionally contributes to both CME and ADBE.
Reduced eEJC amplitudes during LFS and HFS and endocytosis could be a consequence of kis mutant synapses containing fewer synaptic vesicles. To test this possibility, we used the vesicular H+ pump inhibitor, Bafilomycin A1, to block glutamate uptake into vesicles [66]. Because Bafilomycin inhibits the refilling of glutamate into newly endocytosed vesicles, eEJC amplitudes diminish upon successive stimulation as less glutamate is released. eEJC amplitudes were assessed after 20 min incubation with 2 μM Bafilomycin in 1.0 mM Ca2+ during 3 or 10 Hz stimulation. 3 Hz stimulation promotes vesicle release from the readily releasable and recycling vesicle pools while 10 Hz stimulation mobilizes the reserve pool of vesicles [67]. kis mutants exhibited a more pronounced reduction in eEJC amplitudes relative to the first stimuli during both 3 and 10 Hz stimulation compared with w1118 controls (Fig 6). These data indicate kis mutant synapses possess fewer vesicles.
Kismet is important in postsynaptic muscles for endocytosis
We performed rescue experiments to determine the tissue-specific requirements of Kis for endocytosis and locomotor behavior. We restored kis expression in kisLM27/kisk13416 mutants by expressing UAS-kis-L in all tissues using the Actin5c-Gal4 driver, neurons using the elav-Gal4 driver, postsynaptic muscle using the 24B-Gal4 driver, or glial cells using the repo-Gal4 driver. Endocytosis was induced by one min stimulation with 90 mM KCl in HL-3 containing 1.0 mM Ca2+ [34]. Expression of kis-L in all tissues restored endocytosis (S4A and S4B Fig). There were slight but significant reductions in endocytosis, as indicated by reduced FM 1-43FX internalization, when kis-L was expressed in neurons or glia of kis mutants compared with UAS but not driver-specific outcrossed controls (Fig 7A and 7B). When kis-L was expressed in muscles of kis mutants using the 24B-Gal4 driver, however, endocytosis was increased compared with the muscle-specific outcrossed control. There was no difference in endocytosis between kis mutants expressing kis-L in postsynaptic muscle and UAS-kis-L/+ outcrossed controls (Fig 7A and 7B). These data indicate that Kis specifically functions postsynaptically to promote endocytosis as postsynaptic kis-L expression in kisLM27/kisk13416 mutants partially rescues endocytic deficits.
To further probe the tissue-specific contributions of Kis, we knocked down Kis in all tissues, neurons, or postsynaptic muscle to determine if we could mimic the reduction in endocytosis in kis mutants. Expression of UAS-kisRNAi.b was previously shown to reduce Kis levels by 90% in third instar wing discs [29] and reduces kis transcripts by 56.2% in all tissues (S4C Fig). When Kis was knocked down in all tissues using the Actin5c-Gal4 driver, the intensity of the FM signal was decreased to approximately 76.7% of control levels. Similarly, knock down of Kis in postsynaptic muscles using the 24B-Gal4 driver, resulted in a 76.8% decrease in endocytosis (Fig 7C). These values are similar to those of kisLM27/kisk13416 mutants, which exhibit a 72.6% decrease in endocytosis. There was no change in endocytosis when Kis was knocked down in neurons (Fig 7C). These data support the hypothesis that postsynaptic Kis regulates presynaptic endocytosis.
Kis mutants show impaired locomotor behaviors with reductions in the velocity of movement and total distance traveled (Fig 7D). Expression of UAS-kis-L in all tissues of kisLM27/kisk13416 mutants using the Actin5c-Gal4 driver resulted in increases in total distance traveled and both the average and maximum velocity of larval movement (Fig 7D). In contrast, expression of UAS-kis-L in neurons or muscles of kisLM27/kisk13416 mutants did not affect larval movement compared with controls (Fig 7D). These data indicate that Kis functions in all tissues to promote proper larval locomotion.
Expression of human CHD7 in kis mutants restores locomotion but not endocytosis
Kis is 63% identical to human CHD7 with notable conservation within all major functional domains [26]. CHD7 regulates the transcription of gene products that promote migration of neural crest cells [68] but is also expressed in human adult cortical neurons [22]. Because CHD7 influences the expression of genes required for cell adhesion, neurotransmission, and synaptic plasticity [69], we sought to determine whether expression of human CHD7 in kis mutants would restore endocytosis and locomotion. We expressed a Drosophila optimized human CHD7 in all tissues, neurons, or postsynaptic muscles in kisLM27/kisk13416 mutants after verifying that CHD7-V5 was expressed in the nuclei of these tissues (S5A Fig). Although there was some extranuclear/cytoplasmic V5 signal, the most intense signal was localized to the nucleus. Transgenic expression of CHD7 was accomplished in all tissues using the Actin5c-Gal4 driver, in neurons using the elav-Gal4 driver, or in postsynaptic muscle using the 24B-Gal4 driver in kisLM27/kisk13416 mutants. Expression of CHD7 in all three tissue types restored the maximum velocity of larval movement and distance traveled (Fig 8A and 8B). CHD7 expression in all tissues produced a significant increase in average velocity of larval movement while CHD7 expression in neurons or postsynaptic muscle did not restore this aspect of behavior (Fig 8A and 8B). Conversely, expression of CHD7 failed to restore endocytosis as indicated by internalization of FM 1-43FX (Fig 8C and 8D). Expression of CHD7 in all tissues or postsynaptic muscle instead resulted in reduced endocytosis compared with the UAS control but not the Gal4 control (Fig 8C and 8D). These data indicate that CHD7 restores locomotion, but not endocytosis, in kisLM27/kisk13416 mutants.
Expression of an ATPase deficient Kis in kis mutants rescues endocytosis and behavior
If the chromatin remodeling activity of Kis is important for endocytosis, we would expect that expression of an ATPase deficient Kis in kis mutants would fail to rescue either endocytosis and/or behavior. We mutated the Lys residue within the conserved ATP binding site [70] to an Arg (KisK2060R). Mutation of this Lys residue results in the inability of ATPases, including the mammalian Kis homolog, CHD8 [71], to hydrolyze ATP and remodel chromatin [72, 73]. We expressed UAS-kisK2060R in all tissues, neurons, or postsynaptic muscles in kisLM27/kisk13416 mutants. We verified KisK2060R-V5 was expressed in the nuclei of each tissue (S5B Fig). Similar as CHD7-V5, we noted that there was some extranuclear/cytoplasmic signal, which was most apparent in postsynaptic tissue where KisK2060R-V5 exhibited a punctate nuclear and extranuclear distribution. Notably, this signal was not present in the muscle nuclei of larvae expressing UAS-kisK2060R in neurons. Expression of KisK2060R in all tissues, neurons, or postsynaptic muscles in kisLM27/kisk13416 mutants restored both endocytosis (Fig 9C and 9D) and locomotor behavior (Fig 9A and 9B) as there were no significant differences in locomotion or endocytosis between experimental animals and outcrossed controls. These findings suggest that Kis may have functional implications at the synapse that are, at least partly, independent of its chromatin remodeling activity.
Discussion
Our data indicate that Kis promotes both CME and ADBE possibly by regulating the expression of gene products that mediate these processes (Fig 1) and maintaining synaptic vesicle pools (Fig 6). Kis is important in postsynaptic muscles for endocytosis as postsynaptic Kis-L expression in kis mutants restores endocytosis (Fig 7). Surprisingly, the ATPase activity of Kis is dispensable for endocytosis and locomotion (Fig 9).
Kis promotes both CME and ADBE
Several forms of endocytosis exist in neurons to collectively internalize nutrients, detect growth and guidance cues, and maintain synaptic membrane homeostasis [13]. While several endocytic mechanisms are thought to replenish synaptic vesicles [11], there is little evidence for kiss-and-run at the Drosophila NMJ [74]. Compensatory endocytosis and ultrafast endocytosis are thought to occur at the NMJ but there are few direct demonstrations of these mechanisms [12]. CME is thought to be the most prevalent form of endocytosis at the synapse [11] but is limited by the duration required to select cargo and activate CME proteins [75]. Other modes of endocytosis, therefore, compensate for these inherent limitations in CME to enable synaptic homeostasis. ADBE, which quickly internalizes large areas of membrane, is utilized during periods of intense neuronal activity [14]. Kis functionally contributes to both forms of endocytosis as evidenced by the reduction in kis mutant eEJC amplitudes during stimulation protocols that induce ADBE (Fig 2) or CME (Fig 3). Further, when ADBE or CME are pharmacologically inhibited, kis mutants do not show further reductions in endocytosis (Figs 4 and 5).
Postsynaptic Kis-L expression in kis mutants rescues endocytosis (Fig 7A and 7B). Similarly, knock down of Kis in postsynaptic muscle and all tissues mimics the kisLM27/kisk13416 mutant phenotype (Fig 7C). These data indicate that postsynaptic Kis regulates presynaptic endocytosis. Although this may seem unexpected, retrograde signaling via cell adhesion molecules (CAMs) and diffusible molecules released postsynaptically regulate many presynaptic processes including the synaptic vesicle cycle [76]. Presynaptic endocytosis is enhanced by production of nitric oxide downstream of N-methyl D-aspartate (NMDA) receptor signaling, which increases production of the membrane lipid phosphatidylinositol 4,5-biphosphate (PIP2) [77]. PIP2 recruits adaptor protein 2 (AP2) to the plasma membrane [78] to enable endocytosis by selecting cargo and binding to clathrin [79]. Transsynaptic crosstalk through CAMs also modulates endocytosis as null mutations in Neuroligin 1 (Nlg1) enhance endocytosis without affecting exocytosis or the size of vesicle pools [80].
Kis restricts the synaptic localization of the CAM FasII [30], the Drosophila ortholog of neural cell adhesion molecule (NCAM). Similarly, loss of function of Chd7 [81] or Chd8 [82] results in differential expression of several CAMs including ncams and nlgs as determined by ChIP-Seq. Kis binds near the regulatory regions of fasII, fasIII, nlg2, and nlg4 in Drosophila intestinal stem cells [83]. NCAM negatively regulates ADBE [84], possibly by activating protein kinase B/Akt [85, 86], and binds directly to AP2 [87]. Therefore, mutations in kis may lead to deficient endocytosis due to the accumulation of CAMs, which might physically restrict invagination of the plasma membrane.
Alternatively, Kis may regulate CME and ADBE by regulating proteins that organize microdomains of the synapse like Rabs. Rab GTPases facilitate directional membrane trafficking between compartments of the endomembrane system [88]. Specifically, Rab11 traffics cargo between recycling endosomes and the plasma membrane [89] to influence the concentration of lipids and membrane-associated proteins [90]. Kis promotes the transcription of rab11 and Rab11 localization to the synapse [31]. Rab11, when constitutively active, increases the number of rat cerebellar granule cell neuron terminals executing ADBE. Nlg2, Nlg3, and NCAM were present in bulk endosomes [91] suggesting that Rab11 controls the localization of CAMs by regulating ADBE. Thus, Kis may functionally influence endocytosis by a combination of mechanisms including, but not limited to, regulating the expression of endocytic gene transcripts, expression and/or localization of endocytic proteins, CAMs, and Rab11.
Kis is 63% identical to human CHD7 [26]. Despite this conservation, expression of human CHD7 in all tissues or postsynaptic muscles of kis mutants did not restore endocytosis (Fig 8C and 8D) as was observed with UAS-kis-L expression in the same tissue types (Fig 7A and 7B). CHD family chromatin remodeling enzymes assemble with DNA binding proteins [92], histone methytransferases [93], and other proteins to form large, multisubunit complexes. Although the organization and identities of the subunits and the mechanism by which chromatin remodeling enzyme complexes recognize nucleosomes is poorly understood [94], it is recognized that the complexes are developmental- and tissue-specific [95, 96]. Therefore, it is possible that overexpression of CHD7 might produce a dominant negative effect in kis mutants where CHD7 sequesters other transcriptional regulators rendering them inactive. This possibility, however, seems unlikely because CHD7 expression in all tissues, neurons, or postsynaptic muscle of kis mutants restored locomotor behaviors (Fig 8A and 8B). It is more plausible that this discrepancy arises because different tissue types are required for locomotion and endocytosis. Locomotor behaviors require broader, multi-circuit coordination compared with endocytosis. Larval locomotion is produced by central nervous system central pattern generators, which are subject to upstream cholinergic control, and peripheral motor neurons. This circuit may be initiated independent of, but is modulated by, sensory feedback [97]. Presynaptic endocytosis is influenced by interactions between pre- and postsynaptic cells and associated glia [98]. CHD7 binds to unique regulatory loci in different tissues including human neural crest cells, induced pluripotent stem cell-derived neuroepithelial cells, and induced pluripotent stem cells. Further, CHD7 preferentially associates with the transcription factors TFAP2A and NR2F1/F2 in neural crest cells but not neuroepithelial cells [99]. Thus, more CHD7 sensitive gene products may be required for locomotion compared with endocytosis.
Kis may transcriptionally regulate endocytosis
CHD7, CHD8, and Kis influence the transcription of thousands of gene products [81, 83, 100, 101]. Therefore, it is not surprising that Kis affects the transcript levels of several endocytic genes including AP2α, endoB [31], PI3K92E, and sgg/GSK3β (Fig 1). In Drosophila adult intestinal stem cells, Kis was bound near regulatory sequences for several endocytic genes including amphiphysin, AP2α, clathrin light and clathrin heavy chain, dyn, draper 1, flower, lqf, and synaptojanin [83]. We did not observe altered transcript levels of clathrin heavy chain (Fig 1), amphiphysin, flower, lqf, or synaptojanin [31] via RT-qPCR. Similarly, we did not detect Kis binding to the promoter or within 200 bp of the transcription start site of dyn even though Kis is enriched at the promoters and transcription start sites for dap160 and endoB [31]. These discrepancies likely reflect developmental- and/or tissue-specific differences in chromatin remodeling complexes as a result of differential expression of specific transcription factors [96, 102].
Kis, CHD7, and CHD8 contain several domains including two chromodomains, which bind to methylated N-terminal histone residues [103, 104], and an ATPase domain [105]. The latter repositions histones relative to DNA to expose transcriptional regulatory sequences [106]. We found that expression of an ATPase-dead Kis, KisK2060R, in kis mutants restored locomotor behaviors and endocytosis (Fig 9). Similarly, expression of KisK2060R partially rescued the size of stem cell clones in the kis10D26 loss of function mutant [83]. Taken together, these data suggest that Kis may function independent of its ATPase domain to form functional regulatory transcriptional complexes. Chromatin remodeling proteins are integral components of large, multisubunit complexes, the composition of which differ in a cell- and developmental-dependent manner [95, 96]. In Drosophila intestinal stem cells, Kis colocalizes with the histone methyltransferase, Trithorax related (Trr), to regulate the transcription of target genes [83]. Kis recruits the histone methyltransferases, Trithorax and Absent, Small or Homeotic Discs 1 (ASH1) to Drosophila salivary polytene chromosomes [93]. Similarly, CHD8 recruits ASH2L, which is part of a lysine methyltransferase complex, to regulate gene expression required for differentiation of mouse oligodendrocyte precursor cells. Notably, differentiation was partially restored by inhibition of KDM5, a demethyltransferase, in conditional Chd8 knock outs [107] indicating that CHD8’s role in oligodendrocyte precursor cell differentiation occurs partly because of its ability to recruit histone methyltransferases. KDM5 interacts with Kis and Trr in Drosophila adult heads [108] indicating these complexes may be similar across species.
Collectively, these data are consistent with clinical findings, which show that mutations throughout CHD proteins perturb their function. Approximately 30% of CHARGE-associated Chd7 mutations lie within functional domains including the ATPase domain [28] and the percentage of Chd8 point mutations within the ATPase domain associated with autism spectrum disorders is 8% [109]. Thus, residues throughout CHD7 and CHD8 contribute to their transcriptional function. Indeed, Chd7 mutations in CHARGE patients produce different phenotypes depending on the location with mutations in the chromodomains resulting in the most severe phenotypes [28]. Similarly, while mutations in the chromodomains of zebrafish chd7 produce the morphological characteristics of CHARGE Syndrome including craniofacial defects, mutations in the ATPase domain do not [110].
Alternatively, the capacity of KisK2060R to restore locomotor behaviors and endocytosis in kis mutants may occur due to a novel cytoplasmic role for Kis. Other components of chromatin remodeling complexes including the MYST family of acetyltransferases [111] and members of the histone deacetyltransferase (HDAC) family [112] are localized in both the nucleus and cytoplasm where they recognize cytoplasmic substrates. CHD1 [113] and CHD9 [114] were detected in the cytoplasm of mitotic cells. We have not detected Kis in the cytoplasm of ventral nerve cord neurons or postsynaptic muscle cells [30]. Given that 1) Kis binds to regulatory regions of the endocytic genes dap160 and endoB [31], 2) chromatin remodeling enzymes are integral components of transcriptional complexes that include additional proteins that influence transcription, and 3) mutations outside the ATPase domain of CHD proteins exert the most severe phenotypes, we favor the hypothesis that Kis may influence transcription independent of its ATPase domain.
Implications for neurodevelopmental disorders and neurodegenerative diseases
The synaptic vesicle cycle, which includes processes that enable release and recycling of vesicles, is disrupted in neurodevelopmental disorders [115] and neurodegenerative diseases [76]. Genes that regulate the synaptic vesicle cycle are differentially expressed in human Alzheimer’s disease patient neurons [116–118]. It is unclear, however, whether these genetic changes precede the formation of amyloid β (Aβ) plaques, which are produced by proteolytic cleavage of amyloid precursor protein (APP) [25]. Cellular exposure to Aβ40 and Aβ42 aggregates impairs endocytosis in PC12 and neuroblastoma cells and Aβ40 slows the intracellular trafficking of recycling endosomes [116]. Impaired trafficking of endosomes containing amyloid precursor protein (APP) exacerbates production of Aβ40 and Aβ42 as the amyloidogenic pathway of APP processing is favored [119].
Although it is recognized that chromatin remodeling is a contributing factor to neurodevelopmental disorders including autism spectrum disorders [120], how aberrant chromatin remodeling functionally influences the synaptic vesicle cycle is relatively unexplored. We find that Kis maintains synaptic vesicle pools as kis mutants exhibit reductions in the sizes of the readily releasable, recycling, and reserve pools of vesicles (Fig 6). CME and ADBE both replenish synaptic vesicle pools [12, 13] but the extent to which each contributes is not well understood. Because the synaptic vesicle cycle is intimately linked to the endomembrane system [121], it may be difficult to distinguish discrete pools of vesicles. The readily releasable pool of vesicles was regenerated from CME while the reserve pool was bolstered by ADBE in cultured rat cerebellar neurons [122]. CME replenished 63% of the vesicle pool in cultured hippocampal neurons at 9 DIV but only 39% at 19 DIV indicating ADBE is preferentially used in mature neurons to replenish synaptic vesicles [123].
The reduced size of synaptic vesicle pools in kis mutants may lead to the decrease in evoked potentials [30], failed homeostatic presynaptic plasticity [124], and impaired motor behavior (Figs 7D, 8A and 8B, 9A and 9B) observed in kis mutants. It is not clear whether deficient endocytosis in kis mutants leads to the decrease in the synaptic vesicle pool or whether kis mutants produce fewer synaptic vesicles de novo. Our data begins to uncover correlates between aberrant chromatin remodeling and synaptic processes. Given the altered state of chromatin in neurodevelopmental disorders and neurodegenerative diseases [125], a better understanding of the synaptic correlates affecting cognitive and behavioral processes is needed.
Supporting information
Acknowledgments
We thank the Bloomington Drosophila Stock Center for fly stocks (NIH P40OD018537), Carly Gridley for help with the FM 1-43FX rescue experiments, Dave Featherstone for his mentoring, and Southern Illinois University Edwardsville for travel support.
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
Funding Statement
This work was funded by the National Institute of Neurological Disorders and Stroke of the NIH under award numbers 1R15NS101608-01A1 and 2R15NS101608-02A1 (to FL) and by Southern Illinois University Edwardsville’s Competitive Graduate Award (to EH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Katz B, Miledi R. The timing of calcium action during neuromuscular transmission. The Journal of Physiology. 1967;189(3):535–44. doi: 10.1113/jphysiol.1967.sp008183 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Südhof Thomas C. Neurotransmitter Release: The Last Millisecond in the Life of a Synaptic Vesicle. Neuron. 2013;80(3):675–90. doi: 10.1016/j.neuron.2013.10.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Van Vactor D, Sigrist SJ. Presynaptic morphogenesis, active zone organization and structural plasticity in Drosophila. Current Opinion in Neurobiology. 2017;43:119–29. Epub 20170405. doi: 10.1016/j.conb.2017.03.003 ; PubMed Central PMCID: PMC5501089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Katz B, Miledi R. The role of calcium in neuromuscular facilitation. The Journal of Physiology. 1968;195(2):481–92. doi: 10.1113/jphysiol.1968.sp008469 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Doussau F, Schmidt H, Dorgans K, Valera AM, Poulain B, Isope P. Frequency-dependent mobilization of heterogeneous pools of synaptic vesicles shapes presynaptic plasticity. eLife. 2017;6:e28935. doi: 10.7554/eLife.28935 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Rey S, Marra V, Smith C, Staras K. Nanoscale Remodeling of Functional Synaptic Vesicle Pools in Hebbian Plasticity. Cell Reports. 2020;30(6):2006–17.e3. doi: 10.1016/j.celrep.2020.01.051 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Rosenmund C, Stevens CF. Definition of the Readily Releasable Pool of Vesicles at Hippocampal Synapses. Neuron. 1996;16(6):1197–207. doi: 10.1016/s0896-6273(00)80146-4 [DOI] [PubMed] [Google Scholar]
- 8.Pieribone VA, Shupliakov O, Brodin L, Hilfiker-Rothenfluh S, Czernik AJ, Greengard P. Distinct pools of synaptic vesicles in neurotransmitter release. Nature. 1995;375(6531):493–7. doi: 10.1038/375493a0 . [DOI] [PubMed] [Google Scholar]
- 9.Zhang M, Augustine GJ. Synapsins and the Synaptic Vesicle Reserve Pool: Floats or Anchors? Cells. 2021;10(3). Epub 20210316. doi: 10.3390/cells10030658 ; PubMed Central PMCID: PMC8002314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hoopmann P, Punge A, Barysch SV, Westphal V, Bückers J, Opazo F, et al. Endosomal sorting of readily releasable synaptic vesicles. Proceedings of the National Academy of Sciences. 2010;107(44):19055–60. doi: 10.1073/pnas.1007037107 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Chanaday NL, Cousin MA, Milosevic I, Watanabe S, Morgan JR. The Synaptic Vesicle Cycle Revisited: New Insights into the Modes and Mechanisms. J Neurosci. 2019;39(42):8209–16. doi: 10.1523/JNEUROSCI.1158-19.2019 ; PubMed Central PMCID: PMC6794917. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Gan Q, Watanabe S. Synaptic Vesicle Endocytosis in Different Model Systems. Frontiers in Cellular Neuroscience. 2018;12:171. Epub 20180628. doi: 10.3389/fncel.2018.00171 ; PubMed Central PMCID: PMC6031744. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Camblor-Perujo S, Kononenko NL. Brain-specific functions of the endocytic machinery. The FEBS Journal. 2022;289(8):2219–46. doi: 10.1111/febs.15897 [DOI] [PubMed] [Google Scholar]
- 14.Clayton EL, Cousin MA. The molecular physiology of activity-dependent bulk endocytosis of synaptic vesicles. Journal of Neurochemistry. 2009;111(4):901–14. Epub 20090916. doi: 10.1111/j.1471-4159.2009.06384.x ; PubMed Central PMCID: PMC2871311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Bonnycastle K, Davenport EC, Cousin MA. Presynaptic dysfunction in neurodevelopmental disorders: Insights from the synaptic vesicle life cycle. Journal of Neurochemistry. 2021;157(2):179–207. doi: 10.1111/jnc.15035 [DOI] [PubMed] [Google Scholar]
- 16.Schreij AM, Fon EA, McPherson PS. Endocytic membrane trafficking and neurodegenerative disease. Cell Mol Life Sci. 2016;73(8):1529–45. Epub 20151231. doi: 10.1007/s00018-015-2105-x . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Sweatt JD. The emerging field of neuroepigenetics. Neuron. 2013;80(3):624–32. doi: 10.1016/j.neuron.2013.10.023 ; PubMed Central PMCID: PMC3878295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kim S, Kaang BK. Epigenetic regulation and chromatin remodeling in learning and memory. Exp Mol Med. 2017;49(1):e281. Epub 20170113. doi: 10.1038/emm.2016.140 ; PubMed Central PMCID: PMC5291841. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Wilson KD, Porter EG, Garcia BA. Reprogramming of the epigenome in neurodevelopmental disorders. Crit Rev Biochem Mol Biol. 2022;57(1):73–112. Epub 20211002. doi: 10.1080/10409238.2021.1979457 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Berson A, Nativio R, Berger SL, Bonini NM. Epigenetic Regulation in Neurodegenerative Diseases. Trends Neurosci. 2018;41(9):587–98. Epub 20180607. doi: 10.1016/j.tins.2018.05.005 ; PubMed Central PMCID: PMC6174532. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Manning BJ, Yusufzai T. The ATP-dependent chromatin remodeling enzymes CHD6, CHD7, and CHD8 exhibit distinct nucleosome binding and remodeling activities. Journal of Biological Chemistry. 2017;292(28):11927–36. Epub 20170521. doi: 10.1074/jbc.M117.779470 ; PubMed Central PMCID: PMC5512084. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Weng MK, Zimmer B, Poltl D, Broeg MP, Ivanova V, Gaspar JA, et al. Extensive transcriptional regulation of chromatin modifiers during human neurodevelopment. PLoS One. 2012;7(5):e36708. Epub 20120509. doi: 10.1371/journal.pone.0036708 ; PubMed Central PMCID: PMC3348879. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Parikshak NN, Gandal MJ, Geschwind DH. Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders. Nat Rev Genet. 2015;16(8):441–58. Epub 20150707. doi: 10.1038/nrg3934 ; PubMed Central PMCID: PMC4699316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Restrepo LJ, DePew AT, Moese ER, Tymanskyj SR, Parisi MJ, Aimino MA, et al. gamma-secretase promotes Drosophila postsynaptic development through the cleavage of a Wnt receptor. Dev Cell. 2022;57(13):1643–60 e7. Epub 20220601. doi: 10.1016/j.devcel.2022.05.006 ; PubMed Central PMCID: PMC9283269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease. Nat Med. 1996;2(8):864–70. doi: 10.1038/nm0896-864 . [DOI] [PubMed] [Google Scholar]
- 26.Latcheva NK, Ghosh R, Marenda DR. The epigenetics of CHARGE syndrome. Frontiers in Biology. 2016;11(2):85–95. doi: 10.1007/s11515-016-1398-y [DOI] [Google Scholar]
- 27.Saladi SV, de la Serna IL. ATP dependent chromatin remodeling enzymes in embryonic stem cells. Stem Cell Reviews and Reports. 2010;6(1):62–73. doi: 10.1007/s12015-010-9120-y ; PubMed Central PMCID: PMC2862992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Basson MA, van Ravenswaaij-Arts C. Functional Insights into Chromatin Remodelling from Studies on CHARGE Syndrome. Trends in Genetics. 2015;31(10):600–11. Epub 20150924. doi: 10.1016/j.tig.2015.05.009 ; PubMed Central PMCID: PMC4604214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Melicharek DJ, Ramirez LC, Singh S, Thompson R, Marenda DR. Kismet/CHD7 regulates axon morphology, memory and locomotion in a Drosophila model of CHARGE syndrome. Human Molecular Genetics. 2010;19(21):4253–64. Epub 20100817. doi: 10.1093/hmg/ddq348 ; PubMed Central PMCID: PMC2951870. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ghosh R, Vegesna S, Safi R, Bao H, Zhang B, Marenda DR, et al. Kismet positively regulates glutamate receptor localization and synaptic transmission at the Drosophila neuromuscular junction. PLoS One. 2014;9(11):e113494. Epub 20141120. doi: 10.1371/journal.pone.0113494 ; PubMed Central PMCID: PMC4239079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Latcheva NK, Delaney TL, Viveiros JM, Smith RA, Bernard KM, Harsin B, et al. The CHD Protein, Kismet, is Important for the Recycling of Synaptic Vesicles during Endocytosis. Scientific Reports. 2019;9(1):19368. doi: 10.1038/s41598-019-55900-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Melicharek D, Shah A, DiStefano G, Gangemi AJ, Orapallo A, Vrailas-Mortimer AD, et al. Identification of novel regulators of atonal expression in the developing Drosophila retina. Genetics. 2008;180(4):2095–110. Epub 20081001. doi: 10.1534/genetics.108.093302 ; PubMed Central PMCID: PMC2600944. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–8. doi: 10.1006/meth.2001.1262 . [DOI] [PubMed] [Google Scholar]
- 34.Verstreken P, Ohyama T, Bellen HJ. FM 1–43 labeling of synaptic vesicle pools at the Drosophila neuromuscular junction. Methods Mol Biol. 2008;440:349–69. doi: 10.1007/978-1-59745-178-9_26 ; PubMed Central PMCID: PMC2712823. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676–82. Epub 20120628. doi: 10.1038/nmeth.2019 ; PubMed Central PMCID: PMC3855844. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Nussbaum-Krammer CI, Neto MF, Brielmann RM, Pedersen JS, Morimoto RI. Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans. JoVE. 2015;(95):e52321. doi: 10.3791/52321 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Saheki Y, De Camilli P. Synaptic vesicle endocytosis. Cold Spring Harbor Perspectives in Biology. 2012;4(9):a005645. Epub 20120901. doi: 10.1101/cshperspect.a005645 ; PubMed Central PMCID: PMC3428771. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Alabi AA, Tsien RW. Synaptic vesicle pools and dynamics. Cold Spring Harb Perspect Biol. 2012;4(8):a013680. Epub 20120801. doi: 10.1101/cshperspect.a013680 ; PubMed Central PMCID: PMC3405865. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Morgan JR, Comstra HS, Cohen M, Faundez V. Presynaptic membrane retrieval and endosome biology: defining molecularly heterogeneous synaptic vesicles. Cold Spring Harb Perspect Biol. 2013;5(10):a016915. Epub 20131001. doi: 10.1101/cshperspect.a016915 ; PubMed Central PMCID: PMC3783047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Pechstein A, Bacetic J, Vahedi-Faridi A, Gromova K, Sundborger A, Tomlin N, et al. Regulation of synaptic vesicle recycling by complex formation between intersectin 1 and the clathrin adaptor complex AP2. Proc Natl Acad Sci U S A. 2010;107(9):4206–11. Epub 20100216. doi: 10.1073/pnas.0911073107 ; PubMed Central PMCID: PMC2840162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Sundborger A, Soderblom C, Vorontsova O, Evergren E, Hinshaw JE, Shupliakov O. An endophilin-dynamin complex promotes budding of clathrin-coated vesicles during synaptic vesicle recycling. Journal of Cell Science. 2011;124(Pt 1):133–43. doi: 10.1242/jcs.072686 ; PubMed Central PMCID: PMC3001412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Bai J, Hu Z, Dittman JS, Pym EC, Kaplan JM. Endophilin functions as a membrane-bending molecule and is delivered to endocytic zones by exocytosis. Cell. 2010;143(3):430–41. doi: 10.1016/j.cell.2010.09.024 ; PubMed Central PMCID: PMC2996235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Chou VT, Johnson SA, Van Vactor D. Synapse development and maturation at the drosophila neuromuscular junction. Neural Development. 2020;15(1):11. doi: 10.1186/s13064-020-00147-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Nicholson-Fish JC, Cousin MA, Smillie KJ. Phosphatidylinositol 3-Kinase Couples Localised Calcium Influx to Activation of Akt in Central Nerve Terminals. Neurochem Res. 2016;41(3):534–43. Epub 20150722. doi: 10.1007/s11064-015-1663-5 ; PubMed Central PMCID: PMC4799249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Long AA, Mahapatra CT, Woodruff EA, 3rd, Rohrbough J, Leung HT, Shino S, et al. The nonsense-mediated decay pathway maintains synapse architecture and synaptic vesicle cycle efficacy. J Cell Sci. 2010;123(Pt 19):3303–15. Epub 20100907. doi: 10.1242/jcs.069468 ; PubMed Central PMCID: PMC2939802. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Muller M, Liu KS, Sigrist SJ, Davis GW. RIM controls homeostatic plasticity through modulation of the readily-releasable vesicle pool. J Neurosci. 2012;32(47):16574–85. doi: 10.1523/JNEUROSCI.0981-12.2012 ; PubMed Central PMCID: PMC3523185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Heerssen H, Fetter RD, Davis GW. Clathrin dependence of synaptic-vesicle formation at the Drosophila neuromuscular junction. Curr Biol. 2008;18(6):401–9. doi: 10.1016/j.cub.2008.02.055 ; PubMed Central PMCID: PMC2699046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Cadavid AL, Ginzel A, Fischer JA. The function of the Drosophila fat facets deubiquitinating enzyme in limiting photoreceptor cell number is intimately associated with endocytosis. Development. 2000;127(8):1727–36. doi: 10.1242/dev.127.8.1727 . [DOI] [PubMed] [Google Scholar]
- 49.Clayton EL, Evans GJ, Cousin MA. Activity-dependent control of bulk endocytosis by protein dephosphorylation in central nerve terminals. J Physiol. 2007;585(Pt 3):687–91. Epub 20070621. doi: 10.1113/jphysiol.2007.137539 ; PubMed Central PMCID: PMC2375512. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Zhu Y, Xu J, Heinemann SF. Two pathways of synaptic vesicle retrieval revealed by single-vesicle imaging. Neuron. 2009;61(3):397–411. doi: 10.1016/j.neuron.2008.12.024 ; PubMed Central PMCID: PMC2707496. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Sun T, Wu XS, Xu J, McNeil BD, Pang ZP, Yang W, et al. The role of calcium/calmodulin-activated calcineurin in rapid and slow endocytosis at central synapses. J Neurosci. 2010;30(35):11838–47. doi: 10.1523/JNEUROSCI.1481-10.2010 ; PubMed Central PMCID: PMC2954493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Wu XS, McNeil BD, Xu J, Fan J, Xue L, Melicoff E, et al. Ca(2+) and calmodulin initiate all forms of endocytosis during depolarization at a nerve terminal. Nat Neurosci. 2009;12(8):1003–10. Epub 20090726. doi: 10.1038/nn.2355 ; PubMed Central PMCID: PMC4887276. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Morton A, Marland JR, Cousin MA. Synaptic vesicle exocytosis and increased cytosolic calcium are both necessary but not sufficient for activity-dependent bulk endocytosis. J Neurochem. 2015;134(3):405–15. Epub 20150514. doi: 10.1111/jnc.13132 ; PubMed Central PMCID: PMC4950031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Augustine GJ, Santamaria F, Tanaka K. Local calcium signaling in neurons. Neuron. 2003;40(2):331–46. doi: 10.1016/s0896-6273(03)00639-1 . [DOI] [PubMed] [Google Scholar]
- 55.Yamashita T. Ca2+-dependent regulation of synaptic vesicle endocytosis. Neurosci Res. 2012;73(1):1–7. Epub 20120303. doi: 10.1016/j.neures.2012.02.012 . [DOI] [PubMed] [Google Scholar]
- 56.Nakamura Y. EGTA Can Inhibit Vesicular Release in the Nanodomain of Single Ca(2+) Channels. Front Synaptic Neurosci. 2019;11:26. Epub 20191001. doi: 10.3389/fnsyn.2019.00026 ; PubMed Central PMCID: PMC6779814. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Zhou S, Yuan X, Liu Q, Zhang X, Pan X, Zang L, et al. BAPTA-AM, an intracellular calcium chelator, inhibits RANKL-induced bone marrow macrophages differentiation through MEK/ERK, p38 MAPK and Akt, but not JNK pathways. Cytokine. 2010;52(3):210–4. Epub 20100727. doi: 10.1016/j.cyto.2010.07.003 . [DOI] [PubMed] [Google Scholar]
- 58.Kirchhausen T, Macia E, Pelish HE. Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis. Methods Enzymol. 2008;438:77–93. doi: 10.1016/S0076-6879(07)38006-3 ; PubMed Central PMCID: PMC2796620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T. Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell. 2006;10(6):839–50. doi: 10.1016/j.devcel.2006.04.002 . [DOI] [PubMed] [Google Scholar]
- 60.Clayton EL, Anggono V, Smillie KJ, Chau N, Robinson PJ, Cousin MA. The phospho-dependent dynamin-syndapin interaction triggers activity-dependent bulk endocytosis of synaptic vesicles. J Neurosci. 2009;29(24):7706–17. doi: 10.1523/JNEUROSCI.1976-09.2009 ; PubMed Central PMCID: PMC2713864. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Vijayakrishnan N, Woodruff EA, 3rd, Broadie K. Rolling blackout is required for bulk endocytosis in non-neuronal cells and neuronal synapses. J Cell Sci. 2009;122(Pt 1):114–25. Epub 20081209. doi: 10.1242/jcs.036673 ; PubMed Central PMCID: PMC2714403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Evans GJ, Cousin MA. Activity-dependent control of slow synaptic vesicle endocytosis by cyclin-dependent kinase 5. J Neurosci. 2007;27(2):401–11. doi: 10.1523/JNEUROSCI.3809-06.2007 ; PubMed Central PMCID: PMC2099210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Pao PC, Tsai LH. Three decades of Cdk5. J Biomed Sci. 2021;28(1):79. Epub 20211123. doi: 10.1186/s12929-021-00774-y ; PubMed Central PMCID: PMC8609871. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Yao CK, Liu YT, Lee IC, Wang YT, Wu PY. A Ca2+ channel differentially regulates Clathrin-mediated and activity-dependent bulk endocytosis. PLoS Biol. 2017;15(4):e2000931. Epub 20170417. doi: 10.1371/journal.pbio.2000931 ; PubMed Central PMCID: PMC5393565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Daniel JA, Chau N, Abdel-Hamid MK, Hu L, von Kleist L, Whiting A, et al. Phenothiazine-derived antipsychotic drugs inhibit dynamin and clathrin-mediated endocytosis. Traffic. 2015;16(6):635–54. Epub 20150409. doi: 10.1111/tra.12272 . [DOI] [PubMed] [Google Scholar]
- 66.Cavelier P, Attwell D. Neurotransmitter depletion by bafilomycin is promoted by vesicle turnover. Neurosci Lett. 2007;412(2):95–100. Epub 20061122. doi: 10.1016/j.neulet.2006.10.040 ; PubMed Central PMCID: PMC6930131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Delgado R, Maureira C, Oliva C, Kidokoro Y, Labarca P. Size of vesicle pools, rates of mobilization, and recycling at neuromuscular synapses of a Drosophila mutant, shibire. Neuron. 2000;28(3):941–53. doi: 10.1016/s0896-6273(00)00165-3 . [DOI] [PubMed] [Google Scholar]
- 68.Bajpai R, Chen DA, Rada-Iglesias A, Zhang J, Xiong Y, Helms J, et al. CHD7 cooperates with PBAF to control multipotent neural crest formation. Nature. 2010;463(7283):958–62. Epub 20100203. doi: 10.1038/nature08733 ; PubMed Central PMCID: PMC2890258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Schulz Y, Freese L, Manz J, Zoll B, Volter C, Brockmann K, et al. CHARGE and Kabuki syndromes: a phenotypic and molecular link. Hum Mol Genet. 2014;23(16):4396–405. Epub 20140404. doi: 10.1093/hmg/ddu156 . [DOI] [PubMed] [Google Scholar]
- 70.Walker JE, Saraste M, Runswick MJ, Gay NJ. Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J. 1982;1(8):945–51. doi: 10.1002/j.1460-2075.1982.tb01276.x ; PubMed Central PMCID: PMC553140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Thompson BA, Tremblay V, Lin G, Bochar DA. CHD8 is an ATP-dependent chromatin remodeling factor that regulates beta-catenin target genes. Mol Cell Biol. 2008;28(12):3894–904. Epub 20080331. doi: 10.1128/MCB.00322-08 ; PubMed Central PMCID: PMC2423111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Corona DF, Langst G, Clapier CR, Bonte EJ, Ferrari S, Tamkun JW, et al. ISWI is an ATP-dependent nucleosome remodeling factor. Mol Cell. 1999;3(2):239–45. doi: 10.1016/s1097-2765(00)80314-7 . [DOI] [PubMed] [Google Scholar]
- 73.Khavari PA, Peterson CL, Tamkun JW, Mendel DB, Crabtree GR. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature. 1993;366(6451):170–4. doi: 10.1038/366170a0 . [DOI] [PubMed] [Google Scholar]
- 74.Dickman DK, Horne JA, Meinertzhagen IA, Schwarz TL. A slowed classical pathway rather than kiss-and-run mediates endocytosis at synapses lacking synaptojanin and endophilin. Cell. 2005;123(3):521–33. doi: 10.1016/j.cell.2005.09.026 . [DOI] [PubMed] [Google Scholar]
- 75.Watanabe S, Boucrot E. Fast and ultrafast endocytosis. Curr Opin Cell Biol. 2017;47:64–71. Epub 20170406. doi: 10.1016/j.ceb.2017.02.013 . [DOI] [PubMed] [Google Scholar]
- 76.Park C, Jung S, Park H. Single vesicle tracking for studying synaptic vesicle dynamics in small central synapses. Curr Opin Neurobiol. 2022;76:102596. Epub 20220706. doi: 10.1016/j.conb.2022.102596 . [DOI] [PubMed] [Google Scholar]
- 77.Micheva KD, Buchanan J, Holz RW, Smith SJ. Retrograde regulation of synaptic vesicle endocytosis and recycling. Nat Neurosci. 2003;6(9):925–32. doi: 10.1038/nn1114 . [DOI] [PubMed] [Google Scholar]
- 78.Smith SM, Smith CJ. Capturing the mechanics of clathrin-mediated endocytosis. Curr Opin Struct Biol. 2022;75:102427. Epub 20220721. doi: 10.1016/j.sbi.2022.102427 . [DOI] [PubMed] [Google Scholar]
- 79.Beacham GM, Partlow EA, Hollopeter G. Conformational regulation of AP1 and AP2 clathrin adaptor complexes. Traffic. 2019;20(10):741–51. Epub 20190806. doi: 10.1111/tra.12677 ; PubMed Central PMCID: PMC6774827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Luo JK, Melland H, Nithianantharajah J, Gordon SL. Postsynaptic Neuroligin-1 Mediates Presynaptic Endocytosis During Neuronal Activity. Front Mol Neurosci. 2021;14:744845. Epub 20211008. doi: 10.3389/fnmol.2021.744845 ; PubMed Central PMCID: PMC8531268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Schnetz MP, Handoko L, Akhtar-Zaidi B, Bartels CF, Pereira CF, Fisher AG, et al. CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression. PLoS Genet. 2010;6(7):e1001023. Epub 20100715. doi: 10.1371/journal.pgen.1001023 ; PubMed Central PMCID: PMC2904778. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Katayama Y, Nishiyama M, Shoji H, Ohkawa Y, Kawamura A, Sato T, et al. CHD8 haploinsufficiency results in autistic-like phenotypes in mice. Nature. 2016;537(7622):675–9. Epub 20160907. doi: 10.1038/nature19357 . [DOI] [PubMed] [Google Scholar]
- 83.Gervais L, van den Beek M, Josserand M, Salle J, Stefanutti M, Perdigoto CN, et al. Stem Cell Proliferation Is Kept in Check by the Chromatin Regulators Kismet/CHD7/CHD8 and Trr/MLL3/4. Dev Cell. 2019;49(4):556–73 e6. doi: 10.1016/j.devcel.2019.04.033 ; PubMed Central PMCID: PMC6547167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Polo-Parada L, Bose CM, Plattner F, Landmesser LT. Distinct roles of different neural cell adhesion molecule (NCAM) isoforms in synaptic maturation revealed by analysis of NCAM 180 kDa isoform-deficient mice. J Neurosci. 2004;24(8):1852–64. doi: 10.1523/JNEUROSCI.4406-03.2004 ; PubMed Central PMCID: PMC6730389. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Neiiendam JL, Kohler LB, Christensen C, Li S, Pedersen MV, Ditlevsen DK, et al. An NCAM-derived FGF-receptor agonist, the FGL-peptide, induces neurite outgrowth and neuronal survival in primary rat neurons. J Neurochem. 2004;91(4):920–35. doi: 10.1111/j.1471-4159.2004.02779.x . [DOI] [PubMed] [Google Scholar]
- 86.Smillie KJ, Cousin MA. Akt/PKB controls the activity-dependent bulk endocytosis of synaptic vesicles. Traffic. 2012;13(7):1004–11. Epub 20120429. doi: 10.1111/j.1600-0854.2012.01365.x ; PubMed Central PMCID: PMC3488115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Shetty A, Sytnyk V, Leshchyns’ka I, Puchkov D, Haucke V, Schachner M. The neural cell adhesion molecule promotes maturation of the presynaptic endocytotic machinery by switching synaptic vesicle recycling from adaptor protein 3 (AP-3)- to AP-2-dependent mechanisms. J Neurosci. 2013;33(42):16828–45. doi: 10.1523/JNEUROSCI.2192-13.2013 ; PubMed Central PMCID: PMC6618524. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Kiral FR, Kohrs FE, Jin EJ, Hiesinger PR. Rab GTPases and Membrane Trafficking in Neurodegeneration. Curr Biol. 2018;28(8):R471–R86. doi: 10.1016/j.cub.2018.02.010 ; PubMed Central PMCID: PMC5965285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Nieuwenhuis B, Eva R. ARF6 and Rab11 as intrinsic regulators of axon regeneration. Small GTPases. 2020;11(6):392–401. Epub 20180517. doi: 10.1080/21541248.2018.1457914 ; PubMed Central PMCID: PMC6124649. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Rozes-Salvador V, Gonzalez-Billault C, Conde C. The Recycling Endosome in Nerve Cell Development: One Rab to Rule Them All? Front Cell Dev Biol. 2020;8:603794. Epub 20201210. doi: 10.3389/fcell.2020.603794 ; PubMed Central PMCID: PMC7793921. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Kokotos AC, Peltier J, Davenport EC, Trost M, Cousin MA. Activity-dependent bulk endocytosis proteome reveals a key presynaptic role for the monomeric GTPase Rab11. Proc Natl Acad Sci U S A. 2018;115(43):E10177–E86. Epub 20181009. doi: 10.1073/pnas.1809189115 ; PubMed Central PMCID: PMC6205440. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Sokpor G, Castro-Hernandez R, Rosenbusch J, Staiger JF, Tuoc T. ATP-Dependent Chromatin Remodeling During Cortical Neurogenesis. Front Neurosci. 2018;12:226. Epub 20180409. doi: 10.3389/fnins.2018.00226 ; PubMed Central PMCID: PMC5900035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Dorighi KM, Tamkun JW. The trithorax group proteins Kismet and ASH1 promote H3K36 dimethylation to counteract Polycomb group repression in Drosophila. Development. 2013;140(20):4182–92. Epub 20130904. doi: 10.1242/dev.095786 ; PubMed Central PMCID: PMC3787758. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Jiang D, Li T, Guo C, Tang TS, Liu H. Small molecule modulators of chromatin remodeling: from neurodevelopment to neurodegeneration. Cell Biosci. 2023;13(1):10. Epub 20230116. doi: 10.1186/s13578-023-00953-4 ; PubMed Central PMCID: PMC9841685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Hargreaves DC, Crabtree GR. ATP-dependent chromatin remodeling: genetics, genomics and mechanisms. Cell Res. 2011;21(3):396–420. Epub 20110301. doi: 10.1038/cr.2011.32 ; PubMed Central PMCID: PMC3110148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Meier K, Brehm A. Chromatin regulation: how complex does it get? Epigenetics. 2014;9(11):1485–95. doi: 10.4161/15592294.2014.971580 ; PubMed Central PMCID: PMC4622878. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Gjorgjieva J, Berni J, Evers JF, Eglen SJ. Neural circuits for peristaltic wave propagation in crawling Drosophila larvae: analysis and modeling. Front Comput Neurosci. 2013;7:24. Epub 20130404. doi: 10.3389/fncom.2013.00024 ; PubMed Central PMCID: PMC3616270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Barber CN, Raben DM. Lipid Metabolism Crosstalk in the Brain: Glia and Neurons. Front Cell Neurosci. 2019;13:212. Epub 20190521. doi: 10.3389/fncel.2019.00212 ; PubMed Central PMCID: PMC6536584. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Sanosaka T, Okuno H, Mizota N, Andoh-Noda T, Sato M, Tomooka R, et al. Chromatin remodeler CHD7 targets active enhancer region to regulate cell type-specific gene expression in human neural crest cells. Sci Rep. 2022;12(1):22648. Epub 20221231. doi: 10.1038/s41598-022-27293-6 ; PubMed Central PMCID: PMC9805427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Sugathan A, Biagioli M, Golzio C, Erdin S, Blumenthal I, Manavalan P, et al. CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors. Proc Natl Acad Sci U S A. 2014;111(42):E4468–77. Epub 20141007. doi: 10.1073/pnas.1405266111 ; PubMed Central PMCID: PMC4210312. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Wilkinson B, Grepo N, Thompson BL, Kim J, Wang K, Evgrafov OV, et al. The autism-associated gene chromodomain helicase DNA-binding protein 8 (CHD8) regulates noncoding RNAs and autism-related genes. Transl Psychiatry. 2015;5(5):e568. Epub 20150519. doi: 10.1038/tp.2015.62 ; PubMed Central PMCID: PMC4471293. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Murawska M, Brehm A. CHD chromatin remodelers and the transcription cycle. Transcription. 2011;2(6):244–53. Epub 20111101. doi: 10.4161/trns.2.6.17840 ; PubMed Central PMCID: PMC3265784. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Flanagan JF, Mi LZ, Chruszcz M, Cymborowski M, Clines KL, Kim Y, et al. Double chromodomains cooperate to recognize the methylated histone H3 tail. Nature. 2005;438(7071):1181–5. doi: 10.1038/nature04290 . [DOI] [PubMed] [Google Scholar]
- 104.Srinivasan S, Dorighi KM, Tamkun JW. Drosophila Kismet regulates histone H3 lysine 27 methylation and early elongation by RNA polymerase II. PLoS Genet. 2008;4(10):e1000217. Epub 20081010. doi: 10.1371/journal.pgen.1000217 ; PubMed Central PMCID: PMC2563034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Hoffmann A, Spengler D. Chromatin Remodeler CHD8 in Autism and Brain Development. J Clin Med. 2021;10(2). Epub 20210119. doi: 10.3390/jcm10020366 ; PubMed Central PMCID: PMC7835889. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Bartholomew B. Regulating the chromatin landscape: structural and mechanistic perspectives. Annu Rev Biochem. 2014;83:671–96. Epub 20140305. doi: 10.1146/annurev-biochem-051810-093157 ; PubMed Central PMCID: PMC4332854. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Zhao C, Dong C, Frah M, Deng Y, Marie C, Zhang F, et al. Dual Requirement of CHD8 for Chromatin Landscape Establishment and Histone Methyltransferase Recruitment to Promote CNS Myelination and Repair. Dev Cell. 2018;45(6):753–68 e8. doi: 10.1016/j.devcel.2018.05.022 ; PubMed Central PMCID: PMC6063525. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Yheskel M, Sidoli S, Secombe J. Proximity labeling reveals a new in vivo network of interactors for the histone demethylase KDM5. Epigenetics Chromatin. 2023;16(1):8. Epub 20230218. doi: 10.1186/s13072-023-00481-y ; PubMed Central PMCID: PMC9938590. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.An Y, Zhang L, Liu W, Jiang Y, Chen X, Lan X, et al. De novo variants in the Helicase-C domain of CHD8 are associated with severe phenotypes including autism, language disability and overgrowth. Hum Genet. 2020;139(4):499–512. Epub 20200124. doi: 10.1007/s00439-020-02115-9 . [DOI] [PubMed] [Google Scholar]
- 110.Hodorovich DR, Lindsley PM, Berry AA, Burton DF, Marsden KC. Morphological and sensorimotor phenotypes in a zebrafish CHARGE syndrome model are domain-dependent. Genes Brain Behav. 2023;22(3):e12839. Epub 20230130. doi: 10.1111/gbb.12839 ; PubMed Central PMCID: PMC10242184. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Sapountzi V, Cote J. MYST-family histone acetyltransferases: beyond chromatin. Cell Mol Life Sci. 2011;68(7):1147–56. Epub 20101204. doi: 10.1007/s00018-010-0599-9 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Cho Y, Cavalli V. HDAC signaling in neuronal development and axon regeneration. Curr Opin Neurobiol. 2014;27:118–26. Epub 20140412. doi: 10.1016/j.conb.2014.03.008 ; PubMed Central PMCID: PMC4122610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Stokes DG, Perry RP. DNA-binding and chromatin localization properties of CHD1. Mol Cell Biol. 1995;15(5):2745–53. doi: 10.1128/MCB.15.5.2745 ; PubMed Central PMCID: PMC230505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Salomon-Kent R, Marom R, John S, Dundr M, Schiltz LR, Gutierrez J, et al. New Face for Chromatin-Related Mesenchymal Modulator: n-CHD9 Localizes to Nucleoli and Interacts With Ribosomal Genes. J Cell Physiol. 2015;230(9):2270–80. doi: 10.1002/jcp.24960 ; PubMed Central PMCID: PMC6363339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.John A, Ng-Cordell E, Hanna N, Brkic D, Baker K. The neurodevelopmental spectrum of synaptic vesicle cycling disorders. J Neurochem. 2021;157(2):208–28. Epub 20200818. doi: 10.1111/jnc.15135 . [DOI] [PubMed] [Google Scholar]
- 116.Omtri RS, Thompson KJ, Tang X, Gali CC, Panzenboeck U, Davidson MW, et al. Differential Effects of Alzheimer’s Disease Abeta40 and 42 on Endocytosis and Intraneuronal Trafficking. Neuroscience. 2018;373:159–68. Epub 20180111. doi: 10.1016/j.neuroscience.2018.01.003 . [DOI] [PubMed] [Google Scholar]
- 117.Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA. 2010;303(18):1832–40. doi: 10.1001/jama.2010.574 ; PubMed Central PMCID: PMC2989531. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Talwar P, Silla Y, Grover S, Gupta M, Agarwal R, Kushwaha S, et al. Genomic convergence and network analysis approach to identify candidate genes in Alzheimer’s disease. BMC Genomics. 2014;15(1):199. Epub 20140315. doi: 10.1186/1471-2164-15-199 ; PubMed Central PMCID: PMC4028079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Bu G, Cam J, Zerbinatti C. LRP in amyloid-beta production and metabolism. Ann N Y Acad Sci. 2006;1086:35–53. doi: 10.1196/annals.1377.005 . [DOI] [PubMed] [Google Scholar]
- 120.Sullivan JM, De Rubeis S, Schaefer A. Convergence of spectrums: neuronal gene network states in autism spectrum disorder. Curr Opin Neurobiol. 2019;59:102–11. Epub 20190618. doi: 10.1016/j.conb.2019.04.011 ; PubMed Central PMCID: PMC6888864. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Ivanova D, Cousin MA. Synaptic Vesicle Recycling and the Endolysosomal System: A Reappraisal of Form and Function. Front Synaptic Neurosci. 2022;14:826098. Epub 20220225. doi: 10.3389/fnsyn.2022.826098 ; PubMed Central PMCID: PMC8916035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Cheung G, Jupp OJ, Cousin MA. Activity-dependent bulk endocytosis and clathrin-dependent endocytosis replenish specific synaptic vesicle pools in central nerve terminals. J Neurosci. 2010;30(24):8151–61. doi: 10.1523/JNEUROSCI.0293-10.2010 ; PubMed Central PMCID: PMC2889610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123.Park J, Cho OY, Kim JA, Chang S. Endosome-mediated endocytic mechanism replenishes the majority of synaptic vesicles at mature CNS synapses in an activity-dependent manner. Sci Rep. 2016;6:31807. Epub 20160818. doi: 10.1038/srep31807 ; PubMed Central PMCID: PMC4989163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Genc O, An JY, Fetter RD, Kulik Y, Zunino G, Sanders SJ, et al. Homeostatic plasticity fails at the intersection of autism-gene mutations and a novel class of common genetic modifiers. Elife. 2020;9. Epub 20200701. doi: 10.7554/eLife.55775 ; PubMed Central PMCID: PMC7394548. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125.Starr JM. Ageing and epigenetics: linking neurodevelopmental and neurodegenerative disorders. Dev Med Child Neurol. 2019;61(10):1134–8. Epub 20190318. doi: 10.1111/dmcn.14210 . [DOI] [PubMed] [Google Scholar]